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Postoperative Outcomes of Hip Fracture Surgery in Geriatric Patients on 
Clopidogrel or Warfarin at the Time of Surgery 
Abstract 
BACKGROUND: The purpose of our study is to evaluate if surgical intervention in the setting of an 
elevated INR or continued use of clopidogrel lead to elevated post-operative mortality and/or morbidity 
compared to INR reversal or surgical delay. 
METHODS: We retrospectively reviewed 1,007 patients age > 55 undergoing hip fracture fixation at our 
institution over a 10 year span. We placed patients into four groups based upon their anticoagulation 
status at the time of surgery. Descriptive statistics were utilized to evaluate for differences in mortality 
rates, blood loss, time to surgery, and wound complications. 
RESULTS: Comorbid conditions occurred at a higher rate in patients on an anticoagulant. There was found 
to be no difference (p>.05) between all four groups in regards to units of blood transfused, net 
preoperative to post-operative hemoglobin change, 30 day mortality, wound infections, and post-operative 
thromboembolic events. Average time to surgery was less than two days for all groups. 
CONCLUSION: There was no statistically significant increase in local or systemic complications in 
patients who underwent surgery in the setting of an INR > 1.5 or continued use of clopidogrel. Our study 
supports the finding that appropriate and attentive management of anticoagulants from the time of 
admission can minimize surgical delays and result in time to surgery in less than two days for patients 
with an elevated INR at the time of presentation with no effect on mortality or morbidity. 
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Abstract
Background: The purpose of our study is 
to evaluate if surgical intervention in the 
clopidogrel leads to elevated post-operative 
reversal or surgical delay.
Methods: We retrospectively reviewed 1,007 
patients age > 55 years of age that underwent 
10-year period. We placed patients into four 
groups based upon their anticoagulation status 
at the time of surgery. Descriptive statistics 
were utilized to evaluate for differences in 
mortality rates, blood loss, time to surgery, 
and wound complications.
Results: The presence of comorbid conditions 
was noted to be higher in patients on an 
anticoagulant. We found no difference (p>.05) 
between all four groups with regards to 
units of blood transfused, net preoperative 
to post-operative hemoglobin change, 
30-day mortality, wound infections, and 
post-operative thromboembolic events. The 
average time to surgery was less than two 
days for all groups.
Conclusion: There was no statistically 
complications in patients who underwent 
continued use of clopidogrel. Our study 
attentive management of anticoagulants from 
the time of admission can minimize surgical 
delays and result in time to surgery of less 
than two days for patients with an elevated 
adverse effect on mortality or morbidity.
Introduction
Hip fractures are a common injury in the 
elderly population and are associated with 
a high level of morbidity and mortality. 
occur annually, and this number may surpass 
500,000 by the year 2040.1 One-year mortality 
rates of 26% to 33% have been reported.2,3,4 
Many patients require an increased level of 
care 1 year after hip fracture.5,6 
Multiple studies have demonstrated the 
importance of early surgical intervention 
in reducing the morbidity and mortality 
associated with these fractures.1,7,8
demonstrated that patients on Coumadin 
often experience delays in surgical treatment 
9,10 
warfarin management protocol, which allows 
been shown to diminish time to surgery in this 
patient population.9,10 However it is currently 
cut-off to initiate surgical treatment.10
would increase the rate of complications 
such as intraoperative blood loss, there is 
minimal literature demonstrating that such 
complications occur and that reversal is 
necessary. 
The available treatment options for hip 
fractures have varying degrees of invasiveness 
the reversal of Coumadin prior to surgery is 
necessary for some or all of these surgical 
interventions, however it is clear that this 
process can lead to delays in surgery.12,13 
The purpose of our study was to evaluate 
resulted in increased morbidity and mortality. 
We also assessed the time to surgery to 
determine if there was a surgical delay in 
those on Coumadin compared to those not on 
anticoagulants. Our hypothesis was that there 
would be no difference between the groups in 
terms of blood loss or post-operative mortality 
and morbidity. 
Materials and Methods
We retrospectively reviewed 1,007 patients 
age > 55 years of age that underwent hip 
Those who were on the newer anticoagulant 
regimens were excluded. Hip fractures were 
intertrochanteric fractures, or subtrochanteric 
fractures. Periprosthetic fractures, surgical 
treatment for non-unions or malunions 
were excluded, as were patients who 
were less than 55 or with fractures distal 
to the subtrochanteric region. Surgical 
interventions included percutaneous pinning, 
and total hip arthroplasty for fracture. 
We placed patients into four groups based 
upon their status at the time of surgery: 1) 
patients not on Coumadin or clopidogrel; 2) 
patients only on clopidogrel; 3) patients on 
the time of surgery; 4) patients on Coumadin 
of surgery. Descriptive statistics were utilized 
to evaluate for differences in estimated blood 
loss, changes in hemoglobin, transfusion 
rates, mortality rates, time to surgery and 
wound complications. Comparisons were 
also made regarding associated medical 
co-morbidities. Descriptive statistics (counts 
and percentages, means, standard deviations, 
medians, minimums and maximums) were 
used to summarize the data. Fisher’s exact test 
was used to look at associations of categorical 
used to compare continuous data between 
adjusted using Tukey’s test. A p-value < 0.05 
Results
Of the 1007 patients included in the study, 
832, 52, 111 and 12 patients were divided into 
Groups 1, 2, 3 and 4 respectively (Table 1). 
Comorbid conditions including congestive 
heart failure, coronary artery disease, chronic 
kidney disease, and diabetes occurred at a 
higher rate in patients on either anticoagulant 
Table 1.
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when compared to patients not on 
anticoagulants (p<.0001; p<.0001; p=.0035; 
p=.008 respectively). We found no difference 
(p>.05) between all four groups with regards 
to units of blood transfused (p= -0.15), net 
preoperative to post-operative hemoglobin 
change (p=0.44), 30 day mortality(p=0.0689), 
wound infections(p=0.6851), and post-
operative thromboembolic events (p=0.1429) 
the groups with regards to age (p=.52), 
post-operative hgb nadir (p=0.85), and units 
transfused (p=0.15). There was a statistically 
operative blood loss between groups 1 and 3 
(p=.0079). Average time to surgery was 1.6 
days for group 1, 1.9 days for group 2, 1.95 
days for group 3, and 1.42 days in group four 
study.
Multiple studies have demonstrated that 
early surgical intervention in the setting of 
geriatric hip fractures can result in improved 
outcomes.1,2,3 Previous research has shown 
that patients who present with an elevated 
delay which could potentially place them at 
risk for poorer outcomes.4 However to date 
it is unclear if these delays are necessary 
and if early intervention in the setting of an 
in adverse outcomes. Our study found a 
use and presence of other peri-operative 
co-morbidities including congestive heart 
failure, coronary artery disease, chronic 
kidney disease, and diabetes. This suggests 
that even with optimal management of their 
anticoagulation these patients may be at 
increased risk for complications due to these 
associated medical co-morbidities. 
operative blood loss, wound complications, 
post-operative thrombo-embolic incidences 
there was a trend towards increasing mortality 
rates in patients on Coumadin. This may be 
medical co-morbidities noted within these 
to surgery in patients on anticoagulants 
compared to those not on any anticoagulant 
(1.6 days for group one, 1.9 days for group 
two, 1.95 days for group three, and 1.42 days 
in group four (p=0.14)). The mean time to 
surgery for those patients on Coumadin who 
did not undergo surgery until they achieved an 
which show that careful management of these 
patients at the time of admission can minimize 
surgical delays in treatment. 
or systemic complications in patients who 
> 1.5. However due to the small sample size 
in group four (12 patients) we are unable to 
prove or disprove our null hypothesis. Our 
and attentive management of anticoagulants 
from the time of admission can minimize 
surgical delays and result in time to surgery 
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Table 2.
Demographics and variables evaluated amongst the four groups studied showing the Mean with 
Standard deviation, Median, Minimum, and Maximum. All values showed a p>0.5 with the exception of 
comparing Group #1 and Group #3 estimated intra-operative blood loss (p=.0079).
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INR >1.5 (Group #4)
age 
bmi 
time to surgery (days) 
Estimated blood loss 
pre-operative hgb 
postoperative hgb nadir 
units transfused
77.73 
27.03 
1.42 
227.78 
11.64 
8.93 
0.80
8.09 
6.43 
1.56 
203.27 
1.57 
1.20 
1.40
75.00 
30.00 
1.00 
150.00 
11.35 
8.75 
0.00
69.00 
18.51 
0.00 
50.00 
9.70 
6.60 
0.00
92.00 
33.90 
5.00 
700.00 
14.70 
10.90 
4.00
12 
